» Articles » PMID: 27784786

Nrf2 Transcription Factor Can Directly Regulate MTOR: LINKING CYTOPROTECTIVE GENE EXPRESSION TO A MAJOR METABOLIC REGULATOR THAT GENERATES REDOX ACTIVITY

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2016 Oct 28
PMID 27784786
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Nrf2 is a master transcription factor that regulates a wide variety of cellular proteins by recognizing and binding to antioxidant response elements (AREs) in their gene promoter regions. In this study we show that increasing cellular Nrf2 results in transcriptional activation of the gene for mTOR, which is central to the PI3K signaling pathway. This is the case in cells with normal physiological PI3K. However, in cells with abnormally active PI3K increased cellular Nrf2 levels have no effect on mTOR. ChIP assays results show that increased Nrf2 binding is associated with decreased p65 binding and H3-K27me3 signal (marker of gene repression) as well as increased H3-K4me3 signal (marker of gene activation). However, in cells with PI3K activation, no effect of cellular Nrf2 increase on mTOR transcription was observed. In these cells, increasing Nrf2 levels increases Nrf2 promoter binding marginally, whereas p65 binding and H3-K27me3 mark were significantly increased, and H3-K4me3 signal is reduced. Together, these data show for the first time that Nrf2 directly regulates mTOR transcription when the PI3K pathway is intact, whereas this function is lost when PI3K is activated. We have identified a link between the Nrf2 system of sensing environmental stress and mTOR, which is a key cellular protein in metabolism. Studies in cells with activating mutations in the PI3K pathway suggest that Nrf2 transcriptional regulation of mTOR is related to promoter binding of p65 and of methylation of histone residues permissive of transcription.

Citing Articles

Pexophagy and Oxidative Stress: Focus on Peroxisomal Proteins and Reactive Oxygen Species (ROS) Signaling Pathways.

Wei X, Manandhar L, Kim H, Chhetri A, Hwang J, Jang G Antioxidants (Basel). 2025; 14(2).

PMID: 40002313 PMC: 11851658. DOI: 10.3390/antiox14020126.


Imbalance of redox homeostasis and altered cellular signaling induced by the metal complexes of terpyridine.

Malarz K, Ziola P, Zych D, Rurka P, Mrozek-Wilczkiewicz A Sci Rep. 2024; 14(1):26951.

PMID: 39505960 PMC: 11541782. DOI: 10.1038/s41598-024-77575-4.


Tetramethylpyrazine Analogue T-006 Protects Neuronal and Endothelial Cells Against Oxidative Stress via PI3K/AKT/mTOR and Nrf2 Signaling.

Zhang G, Liang Z, Wang Y, Zhang Z, Hoi P Antioxidants (Basel). 2024; 13(10).

PMID: 39456524 PMC: 11505549. DOI: 10.3390/antiox13101272.


Regulatory factors of Nrf2 in age-related macular degeneration pathogenesis.

Hu Z, Wang Y, Lin Z, Ren W, Liu B, Zhao H Int J Ophthalmol. 2024; 17(7):1344-1362.

PMID: 39026906 PMC: 11246936. DOI: 10.18240/ijo.2024.07.21.


Immunoregulation: the interplay between metabolism and redox homeostasis.

Perpinan E, Sanchez-Fueyo A, Safinia N Front Transplant. 2024; 2:1283275.

PMID: 38993920 PMC: 11235320. DOI: 10.3389/frtra.2023.1283275.


References
1.
Johnston S . Enhancing Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: Cotargeting Signaling Pathways. J Natl Cancer Inst. 2015; 107(10). DOI: 10.1093/jnci/djv212. View

2.
Chorley B, Campbell M, Wang X, Karaca M, Sambandan D, Bangura F . Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha. Nucleic Acids Res. 2012; 40(15):7416-29. PMC: 3424561. DOI: 10.1093/nar/gks409. View

3.
Xie T, Belinsky M, Xu Y, Jaiswal A . ARE- and TRE-mediated regulation of gene expression. Response to xenobiotics and antioxidants. J Biol Chem. 1995; 270(12):6894-900. DOI: 10.1074/jbc.270.12.6894. View

4.
Cescon D, She D, Sakashita S, Zhu C, Pintilie M, Shepherd F . NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma. Clin Cancer Res. 2015; 21(11):2499-505. DOI: 10.1158/1078-0432.CCR-14-2206. View

5.
Chan J, Kulke M . Targeting the mTOR signaling pathway in neuroendocrine tumors. Curr Treat Options Oncol. 2014; 15(3):365-79. PMC: 4147239. DOI: 10.1007/s11864-014-0294-4. View